Introduction

Pursuant to Vermont's Pharmaceutical Marketer Price Disclosure law, 18 V.S.A. Section 4633 and a guidance document published by the Vermont Attorney General's Office, GlaxoSmithKline's Web site, http://www.pricedisclosure.gsk.com, provides Vermont-licensed prescribers with an easily accessible repository of average wholesale price (AWP) data for prescription drugs that GlaxoSmithKline (GSK) markets in pill form (eg, tablets, capsules, etc.) in Vermont. GSK obtains the prices contained in this Web site from Clinical Drug Information, LLC, a wholly-owned subsidiary of Wolters Kluwer Health*.

Importantly, the prescribing information approved by the U.S. Food and Drug Administration (FDA) must continue to guide appropriate use of GSK's medicines (prescribing information for GSK's medicines can be accessed on the internet at http://us.gsk.com/en-us/products/prescription-medicines-and-vaccines/). The intent of this Web site is only to provide pricing information to individuals licensed to prescribe drugs by the State of Vermont in accordance with Vermont's law. For more detailed information or healthcare advice, members of the public should consult healthcare professionals.

To access the AWP of a product marketed by GSK and the AWP of other products within the same therapeutic class^†:

• Read Important Information below
• Click Continue
• Click on the appropriate brand name

Important Information

• Listings within these charts do not imply that products are interchangeable or have the same efficacy or safety. Please refer to each product's FDA-approved prescribing information for such determinations. To access approved prescribing information for GSK's products, visit http://us.gsk.com/en-us/products/prescription-medicines-and-vaccines/.


• The prices listed are AWP as established and made available to healthcare providers by Clinical Drug Information, LLC, a wholly-owned subsidiary of Wolters Kluwer Health.* The price paid by consumers may be higher or lower than the prices listed. Information about AWP of these drugs is being provided to Vermont prescribers pursuant to Vermont law, to give you information about the relative prices of marketed drugs and other drugs in the same therapeutic class. The price listed within these charts for a Marketed Product does not represent a price at which GSK sells this product.


• The prices listed do not necessarily reflect price per dosage, price per course of treatment, or the cost effectiveness, of all the products listed. For simplicity, only the smallest package sizes available for each product are included.

*Copyright 2018, Clinical Drug Information, LLC, a wholly-owned subsidiary of Wolters Kluwer Health.

†Therapeutic class is determined by the American Hospital Formulary Service Pharmacologic-Therapeutic Classification, published by the American Society of Health System Pharmacists, which is available on the internet at http://www.ashp.org/ahfs.